Miller, D H <br/><br/>
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.  [electronic resource] 

 -  Neurology  Apr 2007 
 - 1390-401 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/01.wnl.0000260064.77700.fd  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Brain--pathology<br/>Contrast Media<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Gadolinium<br/>Humans<br/>Image Processing, Computer-Assisted<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Natalizumab<br/>Organ Size<br/>Treatment Outcome